跳至主要内容
临床试验/NCT07696897
NCT07696897尚未招募不适用

Comparative Diagnostic Accuracy of Procalcitonin Versus Serum Zinc as Biomarkers for the Diagnosis of Ventilator Acquired Pneumonia in Adults Admitted to the ICU

Sohag University1 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2026年7月7日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
84
试验地点
1
主要终点
Diagnostic accuracy (AUC) of serum procalcitonin versus serum zinc for identification of bacterial pneumonia

研究概览

简要总结

Ventilator-associated pneumonia (VAP) is a common and serious infection among mechanically ventilated ICU patients. Early diagnosis remains challenging because clinical and radiological findings may lack specificity. Procalcitonin (PCT) is a well-established biomarker of bacterial infection, while serum zinc has recently emerged as a potential marker of immune dysfunction and infection severity. This prospective observational cohort study will compare the diagnostic accuracy of serum procalcitonin and serum zinc for the diagnosis of ventilator-associated pneumonia in 84 adult ICU patients. Diagnostic performance will be assessed using ROC curve analysis, sensitivity, specificity, positive predictive value, and negative predictive value. Associations between biomarker levels, inflammatory markers, disease severity scores, and clinical outcomes will also be evaluated.

详细描述

Ventilator-associated pneumonia (VAP) is a major healthcare-associated infection that develops in patients receiving invasive mechanical ventilation for at least 48 hours. It is associated with prolonged intensive care unit (ICU) stay, increased healthcare costs, greater need for organ support, and increased mortality. Despite advances in critical care, accurate and timely diagnosis of VAP remains challenging because clinical and radiological criteria alone may lack sufficient specificity.

Procalcitonin (PCT) is a well-established biomarker that rises in response to bacterial infections and has been used to support diagnosis, assess disease severity, and guide antibiotic therapy. Zinc is an essential trace element involved in immune regulation, inflammatory response, antioxidant defense, and maintenance of epithelial barrier integrity. Zinc deficiency is common among critically ill patients and has been associated with increased susceptibility to infection and poorer clinical outcomes.

This prospective observational cohort study will be conducted in the Intensive Care Unit of Sohag University Hospital. Eighty-four adult mechanically ventilated ICU patients with suspected ventilator-associated pneumonia will be enrolled. Clinical assessment, laboratory investigations, microbiological cultures, chest imaging, and severity scoring systems including SOFA and CURB-65 will be performed according to the study protocol.

Serum procalcitonin and serum zinc levels will be measured at the time of VAP suspicion and repeated after 72 hours. Blood cultures and respiratory samples will be obtained whenever possible before initiation of antibiotic therapy. Patients will be followed throughout their ICU stay to evaluate disease progression and clinical outcomes.

The primary objective of the study is to compare the diagnostic accuracy of serum procalcitonin and serum zinc for confirmed ventilator-associated pneumonia using receiver operating characteristic (ROC) curve analysis and area under the curve (AUC) measurements.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - Age 18 to 70 years.
  • Adult patients admitted to the Intensive Care Unit.
  • Receiving invasive mechanical ventilation for at least 48 hours.
  • Clinical suspicion of ventilator-associated pneumonia (VAP).
  • New or progressive pulmonary infiltrate on chest imaging.
  • At least two of the following:
  • Fever >38°C or hypothermia <36°C.
  • Leukocytosis (>12,000/mm³) or leukopenia (<4,000/mm³).
  • Purulent tracheal secretions.
  • Worsening oxygenation or increased ventilatory requirements.
  • Written informed consent obtained from the patient or legally authorized representative.

排除标准

  • - Age less than 18 years or greater than 70 years.
  • Known chronic liver disease.
  • End-stage renal disease requiring dialysis.
  • Immunocompromised patients (including HIV infection, chemotherapy, organ transplantation, or long-term immunosuppressive therapy).
  • Current zinc supplementation or known disorders of zinc metabolism.
  • Hematologic malignancies.
  • Autoimmune diseases requiring immunosuppressive treatment.
  • Active non-pulmonary bacterial infection requiring systemic antibiotic therapy.
  • Chronic inflammatory diseases that may affect serum zinc levels.
  • Pregnancy.
  • Refusal or inability to provide informed consent.

结局指标

主要结局

Diagnostic accuracy (AUC) of serum procalcitonin versus serum zinc for identification of bacterial pneumonia

时间窗: At presentation (baseline)

Comparison of the diagnostic performance of serum procalcitonin and serum zinc using receiver operating characteristic (ROC) curve analysis and area under the curve (AUC) for diagnosis of ventilator-associated pneumonia.

次要结局

  • Sensitivity and specificity of serum procalcitonin and serum zinc(At presentation (baseline))
  • Positive predictive value and negative predictive value of serum procalcitonin and serum zinc(At presentation (baseline))
  • Diagnostic performance of combined serum procalcitonin and serum zinc model(At presentation (baseline))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mahmoud Adel Mahmoud

Mahmoud Adel Mahmoud

Sohag University

研究点 (1)

Loading locations...

相似试验

Procalcitonin Versus Serum Zinc for Diagnosis of... | 临床试验